$1.32
0[0.00%]
At close: Apr 26
$1.32
0[0.00%]
After Hours: 4:00PM EDT
Nektar Therapeutics
(NASDAQ:NKTR)Nektar Therapeutics Stock (NASDAQ:NKTR), Insider Trading Activity
Nektar Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
4.923M
Insider Percentage Owned
2.68%
Institutional Shares Held
31.063M
Institutional Percentage Held
16.9%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.014K | $0.68 | -$6.13K | SELL | -3.29% | 265.025K | Feb 20 | View |
| Feb 22, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.606K | $0.68 | -$5.17K | SELL | -3.11% | 236.674K | Feb 20 | View |
| Feb 22, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -20.033K | $0.68 | -$13.62K | SELL | -2.23% | 880.299K | Feb 20 | View |
| Nov 20, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.646K | $0.49 | -$4.73K | SELL | -3.40% | 274.039K | Nov 17 | View |
| Nov 20, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.179K | $0.49 | -$3.52K | SELL | -2.86% | 243.78K | Nov 17 | View |
| Nov 20, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -19.877K | $0.49 | -$9.74K | SELL | -2.16% | 900.332K | Nov 17 | View |
| Sep 20, 2023 | Myriam Curet | DIRECTOR | -4.359K | $0.69 | -$3.01K | SELL | -13.72% | 27.418K | Sep 18 | View |
| Sep 20, 2023 | ROBERT CHESS | DIRECTOR | -10.2K | $0.67 | -$6.83K | SELL | -3.55% | 276.873K | Sep 22 | View |
| Sep 20, 2023 | Robert Jeffrey Ajer | DIRECTOR | -4.359K | $0.69 | -$3.01K | SELL | -11.32% | 34.153K | Sep 18 | View |
| Aug 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.703K | $0.78 | -$7.57K | SELL | -3.31% | 283.685K | Aug 16 | View |
| Aug 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.221K | $0.78 | -$5.63K | SELL | -2.80% | 250.959K | Aug 16 | View |
| Aug 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -19.998K | $0.78 | -$15.60K | SELL | -2.13% | 920.209K | Aug 16 | View |
| Jun 15, 2023 | ROY WHITFIELD | DIRECTOR | -30K | $0.57 | -$17.10K | SELL | -11.27% | 236.25K | Jun 14 | View |
| May 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.791K | $0.72 | -$7.05K | SELL | -3.23% | 293.388K | May 16 | View |
| May 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.543K | $0.72 | -$5.43K | SELL | -2.84% | 257.68K | May 16 | View |
| May 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -20.361K | $0.72 | -$14.66K | SELL | -2.12% | 940.207K | May 16 | View |
| Feb 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -10.484K | $3.00 | -$31.45K | SELL | -3.34% | 303.179K | Feb 16 | View |
| Feb 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -8.275K | $3.00 | -$24.82K | SELL | -3.03% | 265.223K | Feb 16 | View |
| Feb 17, 2023 | Jillian Thomsen | CHIEF FINANCIAL OFFICER | -10.267K | $3.00 | -$30.80K | SELL | -3.17% | 313.497K | Feb 16 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.